A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, William Danilo Fernandes de e FONSECA, Denise Morais da e SARTORI, Alexandrina. COVID-19 and Multiple Sclerosis: a complex relationship possibly aggravated by Low Vitamin D levels. Cells, v. 12, n. 5, p. 1-28, 2023Tradução . . Disponível em: https://doi.org/10.3390/cells12050684. Acesso em: 13 ago. 2024.
APA
Souza, W. D. F. de, Fonseca, D. M. da, & Sartori, A. (2023). COVID-19 and Multiple Sclerosis: a complex relationship possibly aggravated by Low Vitamin D levels. Cells, 12( 5), 1-28. doi:10.3390/cells12050684
NLM
Souza WDF de, Fonseca DM da, Sartori A. COVID-19 and Multiple Sclerosis: a complex relationship possibly aggravated by Low Vitamin D levels [Internet]. Cells. 2023 ; 12( 5): 1-28.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/cells12050684
Vancouver
Souza WDF de, Fonseca DM da, Sartori A. COVID-19 and Multiple Sclerosis: a complex relationship possibly aggravated by Low Vitamin D levels [Internet]. Cells. 2023 ; 12( 5): 1-28.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/cells12050684
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLLARES, Cristhianna Viesti Advincula e DONADI, Eduardo Antônio. Transcriptome profiling in autoimmune diseases. Transcriptomics in health and disease. Tradução . Cham: Springer, 2022. . Disponível em: https://doi.org/10.1007/978-3-030-87821-4_11. Acesso em: 13 ago. 2024.
APA
Collares, C. V. A., & Donadi, E. A. (2022). Transcriptome profiling in autoimmune diseases. In Transcriptomics in health and disease. Cham: Springer. doi:10.1007/978-3-030-87821-4_11
NLM
Collares CVA, Donadi EA. Transcriptome profiling in autoimmune diseases [Internet]. In: Transcriptomics in health and disease. Cham: Springer; 2022. [citado 2024 ago. 13 ] Available from: https://doi.org/10.1007/978-3-030-87821-4_11
Vancouver
Collares CVA, Donadi EA. Transcriptome profiling in autoimmune diseases [Internet]. In: Transcriptomics in health and disease. Cham: Springer; 2022. [citado 2024 ago. 13 ] Available from: https://doi.org/10.1007/978-3-030-87821-4_11
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAGA-SILVA, Thais Fernanda de Campos et al. Systemic infection by non-albicans Candida species affects the development of a murine model of multiple sclerosis. Journal of Fungi, v. 8, n. 4, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3390/jof8040386. Acesso em: 13 ago. 2024.
APA
Fraga-Silva, T. F. de C., Munhoz-Alves, N., Mimura, L. A. N., Oliveira, L. R. C. de, Figueiredo-Godoi, L. M. A., Garcia, M. T., et al. (2022). Systemic infection by non-albicans Candida species affects the development of a murine model of multiple sclerosis. Journal of Fungi, 8( 4), 1-19. doi:10.3390/jof8040386
NLM
Fraga-Silva TF de C, Munhoz-Alves N, Mimura LAN, Oliveira LRC de, Figueiredo-Godoi LMA, Garcia MT, Oliveira ES, Ishikawa LLW, Zorzella-Pezavento SFG, Bonato VLD, Junqueira JC, Bagagli E, Sartori A. Systemic infection by non-albicans Candida species affects the development of a murine model of multiple sclerosis [Internet]. Journal of Fungi. 2022 ; 8( 4): 1-19.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/jof8040386
Vancouver
Fraga-Silva TF de C, Munhoz-Alves N, Mimura LAN, Oliveira LRC de, Figueiredo-Godoi LMA, Garcia MT, Oliveira ES, Ishikawa LLW, Zorzella-Pezavento SFG, Bonato VLD, Junqueira JC, Bagagli E, Sartori A. Systemic infection by non-albicans Candida species affects the development of a murine model of multiple sclerosis [Internet]. Journal of Fungi. 2022 ; 8( 4): 1-19.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/jof8040386
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALMEGRIM, Kelen Cristina Ribeiro et al. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2022.1038338. Acesso em: 13 ago. 2024. , 2022
APA
Malmegrim, K. C. R., Toubert, A., Farge, D., & Rodrigues, M. C. de O. (2022). Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II. Frontiers in Immunology. Lausanne: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.3389/fimmu.2022.1038338
NLM
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
Vancouver
Malmegrim KCR, Toubert A, Farge D, Rodrigues MC de O. Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II [Internet]. Frontiers in Immunology. 2022 ; 13 1-3.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2022.1038338
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Eduardo Duarte et al. The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis. Frontiers Immunology, v. 13, p. 1-10 art. 946698, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.946698. Acesso em: 13 ago. 2024.
APA
Silva, E. D., Ulrich, H., Giacomelli, Á. O., Hartung, H. P., Meuth, S. G., & Peixoto, C. A. (2022). The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis. Frontiers Immunology, 13, 1-10 art. 946698. doi:10.3389/fimmu.2022.946698
NLM
Silva ED, Ulrich H, Giacomelli ÁO, Hartung HP, Meuth SG, Peixoto CA. The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis [Internet]. Frontiers Immunology. 2022 ; 13 1-10 art. 946698.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2022.946698
Vancouver
Silva ED, Ulrich H, Giacomelli ÁO, Hartung HP, Meuth SG, Peixoto CA. The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis [Internet]. Frontiers Immunology. 2022 ; 13 1-10 art. 946698.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2022.946698
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Natália Munhoz et al. Candida tropicalis systemic infection redirects Leukocyte infiltration to the kidneys attenuating encephalomyelitis. Journal of Fungi, v. 7, n. 9, p. 1-20, 2021Tradução . . Disponível em: https://doi.org/10.3390/jof7090757. Acesso em: 13 ago. 2024.
APA
Alves, N. M., Mimura, L. A. N., Viero, R. M., Bagagli, E., Peron, J. P. S., Sartori, A., & Silva, T. F. de C. F. (2021). Candida tropicalis systemic infection redirects Leukocyte infiltration to the kidneys attenuating encephalomyelitis. Journal of Fungi, 7( 9), 1-20. doi:10.3390/jof7090757
NLM
Alves NM, Mimura LAN, Viero RM, Bagagli E, Peron JPS, Sartori A, Silva TF de CF. Candida tropicalis systemic infection redirects Leukocyte infiltration to the kidneys attenuating encephalomyelitis [Internet]. Journal of Fungi. 2021 ; 7( 9): 1-20.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/jof7090757
Vancouver
Alves NM, Mimura LAN, Viero RM, Bagagli E, Peron JPS, Sartori A, Silva TF de CF. Candida tropicalis systemic infection redirects Leukocyte infiltration to the kidneys attenuating encephalomyelitis [Internet]. Journal of Fungi. 2021 ; 7( 9): 1-20.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3390/jof7090757
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Lilian Gomes de et al. Unraveling the link between mitochondrial dynamics and neuroinflammation. Frontiers in Immunology, v. 12, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.624919. Acesso em: 13 ago. 2024.
APA
Oliveira, L. G. de, Angelo, Y. de S., Iglesias, A. H., & Peron, J. P. S. (2021). Unraveling the link between mitochondrial dynamics and neuroinflammation. Frontiers in Immunology, 12, 1-14. doi:10.3389/fimmu.2021.624919
NLM
Oliveira LG de, Angelo Y de S, Iglesias AH, Peron JPS. Unraveling the link between mitochondrial dynamics and neuroinflammation [Internet]. Frontiers in Immunology. 2021 ; 12 1-14.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2021.624919
Vancouver
Oliveira LG de, Angelo Y de S, Iglesias AH, Peron JPS. Unraveling the link between mitochondrial dynamics and neuroinflammation [Internet]. Frontiers in Immunology. 2021 ; 12 1-14.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2021.624919
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANT'ANNA, Morena Brazil Martins et al. The Crotoxin:SBA-15 complex down-regulates the incidence and intensity of experimental autoimmune encephalomyelitis through peripheral and central actions. Frontiers in Immunology, v. 11, p. 13, 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.591563. Acesso em: 13 ago. 2024.
APA
Sant'Anna, M. B. M., Giardini, A. C., Ribeiro, M. A. C., Lopes, F. S. R., Teixeira, N. B., Kimura, L. F., et al. (2020). The Crotoxin:SBA-15 complex down-regulates the incidence and intensity of experimental autoimmune encephalomyelitis through peripheral and central actions. Frontiers in Immunology, 11, 13. doi:10.3389/fimmu.2020.591563
NLM
Sant'Anna MBM, Giardini AC, Ribeiro MAC, Lopes FSR, Teixeira NB, Kimura LF, Buffalo MC, Ribeiro OG, Borrego A, Cabrera WHK, Zambelli VO, Sant'Anna OA, Piccolo G, Ferreira JCB. The Crotoxin:SBA-15 complex down-regulates the incidence and intensity of experimental autoimmune encephalomyelitis through peripheral and central actions [Internet]. Frontiers in Immunology. 2020 ; 11 13.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2020.591563
Vancouver
Sant'Anna MBM, Giardini AC, Ribeiro MAC, Lopes FSR, Teixeira NB, Kimura LF, Buffalo MC, Ribeiro OG, Borrego A, Cabrera WHK, Zambelli VO, Sant'Anna OA, Piccolo G, Ferreira JCB. The Crotoxin:SBA-15 complex down-regulates the incidence and intensity of experimental autoimmune encephalomyelitis through peripheral and central actions [Internet]. Frontiers in Immunology. 2020 ; 11 13.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fimmu.2020.591563
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRAS, Thiago G et al. Outer retinal dysfunction on multifocal electroretinography may help differentiating multiple sclerosis from neuromyelitis optica spectrum disorder. Frontiers in neurology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fneur.2019.00928. Acesso em: 13 ago. 2024.
APA
Filgueiras, T. G., Oyamada, M. K., Preti, R. C., Apostolos-pereira, S. L., Callegaro, D., & Monteiro, M. L. R. (2019). Outer retinal dysfunction on multifocal electroretinography may help differentiating multiple sclerosis from neuromyelitis optica spectrum disorder. Frontiers in neurology, 10. doi:10.3389/fneur.2019.00928
NLM
Filgueiras TG, Oyamada MK, Preti RC, Apostolos-pereira SL, Callegaro D, Monteiro MLR. Outer retinal dysfunction on multifocal electroretinography may help differentiating multiple sclerosis from neuromyelitis optica spectrum disorder [Internet]. Frontiers in neurology. 2019 ; 10[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fneur.2019.00928
Vancouver
Filgueiras TG, Oyamada MK, Preti RC, Apostolos-pereira SL, Callegaro D, Monteiro MLR. Outer retinal dysfunction on multifocal electroretinography may help differentiating multiple sclerosis from neuromyelitis optica spectrum disorder [Internet]. Frontiers in neurology. 2019 ; 10[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fneur.2019.00928
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VASCONCELOS, Andrea Rodrigues et al. Nrf2/ARE pathway modulation by dietary energy regulation in neurological disorders. Frontiers in Pharmacology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fphar.2019.00033. Acesso em: 13 ago. 2024.
APA
Vasconcelos, A. R., Santos, N. B. dos, Scavone, C., & Munhoz, C. D. (2019). Nrf2/ARE pathway modulation by dietary energy regulation in neurological disorders. Frontiers in Pharmacology, 10. doi:10.3389/fphar.2019.00033
NLM
Vasconcelos AR, Santos NB dos, Scavone C, Munhoz CD. Nrf2/ARE pathway modulation by dietary energy regulation in neurological disorders [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fphar.2019.00033
Vancouver
Vasconcelos AR, Santos NB dos, Scavone C, Munhoz CD. Nrf2/ARE pathway modulation by dietary energy regulation in neurological disorders [Internet]. Frontiers in Pharmacology. 2019 ; 10[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fphar.2019.00033
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIACOMELLI, Ágatha Oliveira et al. Purinergic receptors in neurological diseases with motor symptoms: targets for therapy. Frontiers in Pharmacology, v. 9, p. 1-28 art. 325, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00325. Acesso em: 13 ago. 2024.
APA
Giacomelli, Á. O., Naaldijk, Y., Arroyo, L. S., Goncalves, M. C. B., Velloso, J. C., Pillat, M. M., et al. (2018). Purinergic receptors in neurological diseases with motor symptoms: targets for therapy. Frontiers in Pharmacology, 9, 1-28 art. 325. doi:10.3389/fphar.2018.00325
NLM
Giacomelli ÁO, Naaldijk Y, Arroyo LS, Goncalves MCB, Velloso JC, Pillat MM, Souza HDN de, Ulrich H. Purinergic receptors in neurological diseases with motor symptoms: targets for therapy [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-28 art. 325.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fphar.2018.00325
Vancouver
Giacomelli ÁO, Naaldijk Y, Arroyo LS, Goncalves MCB, Velloso JC, Pillat MM, Souza HDN de, Ulrich H. Purinergic receptors in neurological diseases with motor symptoms: targets for therapy [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-28 art. 325.[citado 2024 ago. 13 ] Available from: https://doi.org/10.3389/fphar.2018.00325
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Daniel May de et al. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. Inflammopharmacology, v. 23, n. 6, p. 343-354, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10787-015-0252-1. Acesso em: 13 ago. 2024.
APA
Oliveira, D. M. de, Oliveira, E. M. L. de, Ferrari, M. de F. R., Semedo, P., Hiyane, M. I., Cenedeze, M. A., et al. (2015). Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. Inflammopharmacology, 23( 6), 343-354. doi:10.1007/s10787-015-0252-1
NLM
Oliveira DM de, Oliveira EML de, Ferrari M de FR, Semedo P, Hiyane MI, Cenedeze MA, Pacheco-Silva A, Câmara NOS, Peron JPS. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration [Internet]. Inflammopharmacology. 2015 ; 23( 6): 343-354.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1007/s10787-015-0252-1
Vancouver
Oliveira DM de, Oliveira EML de, Ferrari M de FR, Semedo P, Hiyane MI, Cenedeze MA, Pacheco-Silva A, Câmara NOS, Peron JPS. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration [Internet]. Inflammopharmacology. 2015 ; 23( 6): 343-354.[citado 2024 ago. 13 ] Available from: https://doi.org/10.1007/s10787-015-0252-1